Irreversible Atorvastatin-Associated Hearing Loss-Reference-Cited by-同舟云学术

Irreversible Atorvastatin-Associated Hearing Loss

Published:2012-01-24 Issue:2 Volume:32 Page:e27-e34
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Liu Michael¹,Alafris Antonia¹,Longo Anthony J.²,Cohen Henry¹

Affiliation:

1. The Department of Pharmacy Practice; Arnold and Marie Schwartz College of Pharmacy and Health Sciences; Long Island University; Department of Pharmacy Services; Kingsbrook Jewish Medical Center; Brooklyn New York

2. Scientific Affairs; UCB Pharma; Rochester New York

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/PHAR.1040/fullpdf

Reference35 articles.

1. Third report of the NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report;National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);Circulation,2002

2. USAToday FDA statement on Baycol withdrawal http://www.usatoday.com/money/general/2001-08-08-bayer-fda-statement.htm

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Which Environmental Pollutants Are Toxic to Our Ears?—Evidence of the Ototoxicity of Common Substances;Toxics;2024-09-04

2. Lipids and Statin Medication With Sensorineural Hearing Loss: A Mendelian Randomization Study;The Laryngoscope;2024-05-28

3. High‐throughput screening for prescribing cascades among real world statin initiators;Pharmacoepidemiology and Drug Safety;2023-03-15

4. Statins and hearing;Hearing Research;2022-11

5. Association between Statin Use and Sensorineural Hearing Loss in Type 2 Diabetic Patients: A Hospital-Based Study;Pharmaceuticals;2021-10-25